Efficacy Parameters

• Change in Borg dyspnea index
• Change in WHO functional class
• Change in pulmonary hemodynamics(mean PAP, PVR, CI, mean RAP)
• Increase in therapy for PAH (Period 1)

9850.01

Previous slide

Next slide

Back to first slide

View graphic version